July 28, 2005
Phenex AG widens customer base, maintains profitability and recruits further laboratory staff
The Nuclear Receptor Research Company strengthens its service business while heading for a funding round…
December 3, 2003
PheneX AG launches RE-PheX, a new software tool to mine the human genome for transcription factor control elements
RE-PheX complements PheneX offering for Nuclear Receptor Research assets Ludwigshafen, Germany, December 3rd, 2003 PheneX…
November 13, 2003
PheneX AG acquires assets of Nuclear Receptor Research unit from LION bioscience AG
PheneX founders, team performs a "true" management buy-out Ludwigshafen, Germany, November 13th, 2003 „This is…
Contact
Waldhofer Str. 104
69123 Heidelberg, Germany
Phone: +49 6221 65282-0
Fax: +49 6221 65282-10
Dr. Claus Kremoser
Thomas Hoffmann
mailto: info@phenex-pharma.com
About Phenex Pharmaceuticals AG
Phenex is a privately held drug discovery and development company headquartered in Ludwigshafen with a research site in Heidelberg. The biopharmaceutical company can now build on nineteen years of expertise in exploring and defining innovative, potent and selective new drug candidates from small molecules. Phenex´s R&D activities are centered around diseases of liver such as NASH and cancer.
